These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 17338425)

  • 1. PDGF-B gene single-nucleotide polymorphisms are not predictive for disease onset or progression of IgA nephropathy.
    Bicanski B; Wenderdel M; Mertens PR; Senderek J; Panzer U; Steinmetz O; Stahl RA; Cerullo G; Diletta Torres D; Schena FP; Zerres K; Floege J
    Clin Nephrol; 2007 Feb; 67(2):65-72. PubMed ID: 17338425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renin-angiotensin system gene polymorphisms: its impact on IgAN and its progression to end-stage renal failure among Chinese in Singapore.
    Lau YK; Woo KT; Choong HL; Zhao Y; Tan HB; Chong SM; Tan EK; Yap HK; Wong KS
    Nephron Physiol; 2004; 97(1):p1-8. PubMed ID: 15153745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fractional urinary excretion of IgG is the most powerful predictor of renoprotection by ACE inhibitors in IgA nephropathy.
    Bazzi C; Rizza V; Paparella M; Casellato D; Napodano P; Olivieri G; D'Amico G
    J Nephrol; 2009; 22(3):387-96. PubMed ID: 19557716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease progression, response to ACEI/ATRA therapy and influence of ACE gene in IgA nephritis.
    Woo KT; Lau YK; Zhao Y; Liu FE; Tan HB; Tan EK; Stephanie FC; Chan CM; Wong KS
    Cell Mol Immunol; 2007 Jun; 4(3):227-32. PubMed ID: 17601378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Close relationship of plasminogen activator inhibitor-1 4G/5G polymorphism and progression of IgA nephropathy.
    Suzuki H; Sakuma Y; Kanesaki Y; Eiro M; Asahi K; Sanada H; Watanabe K; Katoh T; Watanabe T
    Clin Nephrol; 2004 Sep; 62(3):173-9. PubMed ID: 15481848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients with IgA nephropathy exhibit high systemic PDGF-DD levels.
    Boor P; Eitner F; Cohen CD; Lindenmeyer MT; ; Mertens PR; Ostendorf T; Floege J
    Nephrol Dial Transplant; 2009 Sep; 24(9):2755-62. PubMed ID: 19357108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation analysis of angiotensin-converting enzyme, angiotensinogen, and endothelial nitric oxide synthase gene polymorphisms and the progression of immunoglobulin A nephropathy/membranous nephropathy.
    Zhu X; Kong D; Zhang L; Sun Y; Na S; Han C; Jin X
    Hum Pathol; 2013 Dec; 44(12):2806-13. PubMed ID: 24157068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients.
    Draman CR; Kong NC; Gafor AH; Rahman AF; Zainuddin S; Mustaffa WM; Radzi AM; Shamsul AS
    Singapore Med J; 2008 Nov; 49(11):924-9. PubMed ID: 19037561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of Progression in IgA Nephropathy in Childhood.
    Mizerska-Wasiak M; Małdyk J; Turczyn A; Cichoń-Kawa K; Rybi-Szumińska A; Wasilewska A; Bieniaś B; Zajączkowska M; Miklaszewska M; Pietrzyk J; Demkow U; Roszkowska-Blaim M; Pańczyk-Tomaszewska M
    Adv Exp Med Biol; 2017; 955():65-73. PubMed ID: 27718216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin-converting enzyme insertion/deletion polymorphism and prognosis of IgA nephropathy.
    Syrjänen J; Huang XH; Mustonen J; Koivula T; Lehtimäki T; Pasternack A
    Nephron; 2000 Oct; 86(2):115-21. PubMed ID: 11014979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical course of patients with IgA nephropathy between combined treatment of immunosuppressive agents and ACE inhibitor and ACE inhibitor alone.
    Hwang YC; Lee TW; Kim MJ; Yang MH; Ihm CG
    Korean J Intern Med; 2001 Jun; 16(2):105-9. PubMed ID: 11590896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ACE gene polymorphism and renal responsiveness to ACE inhibitors in IgA nephropathy patients.
    Han SY; Kwon YJ; Jo SK; Shin JH; Cha DR; Cho WY; Pyo HJ; Kim HK
    Korean J Intern Med; 2000 Jan; 15(1):13-8. PubMed ID: 10714086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACE gene sequence and nucleotide variants in IgA nephropathy.
    Woo KT; Lau YK; Chan CM; Zhao Y; Tan HB; Liu FE; Fook-Chong S; Wong KS
    Singapore Med J; 2011 Nov; 52(11):824-34. PubMed ID: 22173253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of
    Zhong Z; Feng S; Shi D; Xu R; Yin P; Wang M; Mao H; Huang F; Li Z; Yu X; Li M
    DNA Cell Biol; 2019 Oct; 38(10):1155-1165. PubMed ID: 31433201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effects of angiotensin-converting enzyme inhibitor on IgA nephropathy and the influencing factors].
    Shi X; Chen X; Liu S; Zhuang Y; Zhang Y
    Zhonghua Nei Ke Za Zhi; 2002 Jun; 41(6):399-403. PubMed ID: 12137603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variant of C1GalT1 contributes to the susceptibility to IgA nephropathy.
    Pirulli D; Crovella S; Ulivi S; Zadro C; Bertok S; Rendine S; Scolari F; Foramitti M; Ravani P; Roccatello D; Savoldi S; Cerullo G; Lanzilotta SG; Bisceglia L; Zelante L; Floege J; Alexopoulos E; Kirmizis D; Ghiggeri GM; Frascà G; Schena FP; Amoroso A;
    J Nephrol; 2009; 22(1):152-9. PubMed ID: 19229831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CTLA-4 Polymorphisms in Patients with IgA Nephropathy Correlate with Proteinuria.
    Jacob M; Ohl K; Goodarzi T; Harendza S; Eggermann T; Fitzner C; Hilgers RD; Bolte A; Floege J; Rauen T; Tenbrock K
    Kidney Blood Press Res; 2018; 43(2):360-366. PubMed ID: 29539619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ACE gene polymorphism and IgA nephropathy: an ethnically homogeneous study and a meta-analysis.
    Schena FP; D'Altri C; Cerullo G; Manno C; Gesualdo L
    Kidney Int; 2001 Aug; 60(2):732-40. PubMed ID: 11473656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of aldosterone synthase gene C-344T polymorphism on IgA nephropathy.
    Bantis C; Heering PJ; Siekierka-Harreis M; Kouri NM; Schwandt C; Rump LC; Ivens K
    Ren Fail; 2011; 33(4):393-7. PubMed ID: 21476902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A candidate gene approach to genetic prognostic factors of IgA nephropathy--a result of Polymorphism REsearch to DIstinguish genetic factors Contributing To progression of IgA Nephropathy (PREDICT-IgAN).
    Yamamoto R; Nagasawa Y; Shoji T; Inoue K; Uehata T; Kaneko T; Okada T; Yamauchi A; Tsubakihara Y; Imai E; Isaka Y; Rakugi H
    Nephrol Dial Transplant; 2009 Dec; 24(12):3686-94. PubMed ID: 19420105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.